INSIDE INDUSTRY
Abstract
First of Its Kind Treatment – Repatha® (evolocumab) – Available to Address Unmet Needs in Patients with Uncontrolled LDL Cholesterol in Singapore.
Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer.
Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Approval from Singapore’s Health Sciences Authority in Unresectable or Metastatic Melanoma [1].
National Supercomputing Centre Singapore and Global Gene Corp Sign a Strategic Collaboration in Support of Singapore’s Precision Medicine Initiative.
Parkway Pantai Introduces New 3-D Mammography Technology in Singapore Developed by GE Healthcare with More Patient Comfort in Mind.
Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore.
Siemens Launches First Fully Integrated Digitalization Hub in Singapore.
- cholesterol
- low-density lipoprotein (LDL)
- treatment
- cardiovascular diseases (CVD)
- human monoclonal antibody
- mass spectrometer
- unresectable or metastatic melanoma
- monotherapy
- precision medicine
- 3-D mammography technology
- mammograms
- patient comfort
- breast cancer
- breast screening
- oncology
- cutting-edge technologies
- integrated digitalization hub
